HEARTWEAR

Wearable Wireless Kit for Detection and Monitoring of Ischemic Conditions

Coordinatore	AXIO CONSULTING AS    more  Organization address address: ST. OLAVS PLASS 3 city: OSLO postcode: 130 contact info Titolo: Mr. Nome: Arild Cognome: Hermansen Email: send email Telefono: 4791601745 Fax: 4722204801
Nazionalità Coordinatore	Norway [NO]
Totale costo	1˙587˙512 €
EC contributo	1˙244˙000 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2012
Funding Scheme	BSG-SME
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-01-01   -   2014-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	AXIO CONSULTING AS  Organization address address: ST. OLAVS PLASS 3 city: OSLO postcode: 130 contact info Titolo: Mr. Nome: Arild Cognome: Hermansen Email: send email Telefono: 4791601745 Fax: 4722204801	NO (OSLO)	coordinator	621˙354.90
2	HALLMARK ELECTRONICS LIMITED  Organization address address: LOOMER ROAD HALLMARK HOUSE city: NEWCASTLE UNDER LYME postcode: ST5 7LA contact info Titolo: Mr. Nome: Mike Cognome: Mchenry Email: send email Telefono: 448712000000	UK (NEWCASTLE UNDER LYME)	participant	331˙599.53
3	REEVITE INDUSTRIAL MOULDINGS LTD  Organization address address: MURDOCK ROAD BICESTER 16 city: HEREFORD postcode: OX26 4PP contact info Titolo: Mr. Nome: David Cognome: Wilkins Email: send email Telefono: +44 1432 349904	UK (HEREFORD)	participant	141˙066.20
4	INRAY SOLUTIONS LTD  Organization address address: MLADOST 3 COMPLEX BL 302 ENT 4 FL 1 AP 47 city: SOFIA postcode: 1712 contact info Titolo: Mr. Nome: Petar Cognome: Gugutkov Email: send email Telefono: 3599714711	BG (SOFIA)	participant	118˙683.37
5	SORLANDET SYKEHUS HF  Organization address address: EGSVEIEN 100 city: KRISTIANSAND S postcode: 4615 contact info Titolo: Mrs. Nome: Sissel M. Cognome: Ledang Email: send email Telefono: +47 38073308 Fax: +47 38074173	NO (KRISTIANSAND S)	participant	13˙600.00
6	JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH  Organization address address: LEONHARDSTRASSE 59 city: GRAZ postcode: 8010 contact info Titolo: Dr. Nome: Martina Cognome: Uray Email: send email Telefono: 433169000000	AT (GRAZ)	participant	9˙637.00
7	OSAUHING EESTI INNOVATSIOONI INSTITUUT  Organization address address: SEPAPAJA 6 city: TALLINN postcode: 11415 contact info Titolo: Mr. Nome: Lauri Cognome: Nirgi Email: send email Telefono: +37 261 01 014	EE (TALLINN)	participant	8˙059.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Ischemic Heart Disease (IHD) and its direct consequences is the number one cause of death in high income and middle income countries such as EU countries and the number four cause of death in low income countries; in 2008, IHD caused 7.25Mn deaths globally and a little over 1Mn in the European Region. In addition, IHD is the second leading cause of burden of disease (as measured in Disability-Adjusted Life Years or DALYs, or years of lost healthy life) in the high and middle income countries and number nine in low income countries; in the European Region, IHD is the number one cause of disease burden. Between 70% to 90% of the episodes of IHD that can be detected with ECG are clinically silent, with patients unable to report symptoms like chest pain or discomfort. Currently, if an out-patient is suspected to have IHD, he or she is referred to the “stress test” Stress test is relatively expensive in Europe (€3,000 – 4,000 per procedure), requires qualified medical assistance during preparation, testing and result interpretation and has a long waiting period (3 to 6 months). Critical in-patients are normally monitored with the continuous 12 lead ECG for 24-48 hours in the hospital in an even more expensive procedure.

We propose to develop a novel wireless product for preventive screening and monitoring of IHD that is able to monitor patient’s ECG during daily activities over a 24 to 48 hour period with quality of the SoA 12 lead ECG unit as a new type of ambulatory ECG that would cost less than 20% of the stress test. Innovative approaches are to include a truly wireless solution for patient convenience, patient positional information, information of breathing activity and tissue oxygenation as the need for automatic adjustment of continuous ECG signal for patient’s orientation during the cardiac cycle and adjustment for types of physical activity and irregular heartbeats have become the requirement by the medical community.'